Botanical and plant-derived drugs market is expected to grow at a significant CAGR during the forecast period. Botanical drugs are made from plants that have therapeutic properties. Algae and vegetable components, as well as microscopic fungus, are found in botanical drugs. Botanical and plant-derived drugs are used to treat a variety of conditions, including CNS disorders, infectious diseases, CVD, and respiratory diseases. Botanical drugs come in a variety of formats, including pills, tablets, and injections.
Botanical drugs are widely employed for a variety of purposes. The rising prevalence of skin problems is a major factor driving the increased use of botanical drugs in dermatology. Several central nervous system receptors can interact with plant extracts and components to impact pharmacology, making them relevant in the treatment of diseases including central nerve disorders. Hormone illnesses are largely endocrine system diseases that affect the glands of the endocrine system directly. Other disorders with therapeutic applicability include respiratory diseases, joint diseases, and kidney diseases.
To Request a Sample of our Report on Botanical and Plant-Derived Drugs Market: https://www.omrglobal.com/request-sample/botanical-and-plant-derived-drugs-market
The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including product launches, partnerships and collaborations, mergers and acquisitions, geographical expansion to remain competitive in the marketplace. For instance, in November 2021, NFL Biosciences SA, a biopharmaceutical company engaged in the development of botanical drugs for the treatment of addictions, and Diverchim, a French company engaged in the GMP development and production of novel molecules, are announcing that they have set up a partnership. Diverchim will manage the production of liquid protein extracts from tobacco and cannabis leaves, which are the core components of NFL-101, NFL Biosciences’ botanical drug candidate for the treatment of tobacco addiction, and NFL-201, for treating cannabis dependence.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Source
- By Dosage Form
- By Therapeutic Application
- Regions covered–
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape: Bayer Healthcare, LLC, GlaxoSmithKline plc, and GW Pharmaceuticals, plc, among others
Botanical and Plant-Derived Drugs Market Report by Segment
By Source
- Plant
- Algae
- Macroscopic Fungi
- Others
By Dosage Form
- Pills
- Tablets
- Capsules
- Others
By Therapeutic Application
- CVD
- Infectious Diseases
- Dermatology
- Central Nervous System
- Respiratory Diseases
- Others
A full Report of Botanical and Plant-Derived Drugs Market is Available @ https://www.omrglobal.com/industry-reports/botanical-and-plant-derived-drugs-market
Botanical and Plant-Derived Drugs Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
